Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
12/2012
12/18/2012US8333981 Antifungal treatment of nails
12/18/2012US8333959 Ex-vivo application of solid microparticulate therapeutic agents
12/18/2012US8333953 Methods of delivery of exogenous proteins to the cytosol and uses thereof
12/18/2012CA2514552C Adjuvant used in dielectric heating-assisted cancer treatment, and cancer treatment method
12/13/2012WO2012170569A1 Bismuth particle x-ray contrast agents
12/13/2012WO2012169973A1 A core-shell nanoparticle
12/13/2012WO2012167350A1 Method for the synthesis of porphyrin-phospholipid conjugates
12/13/2012US20120317663 Methods of screening agents for activity using teleosts
12/13/2012US20120315220 Compounds for Targeting Endothelial Cells, Compositions Containing the Same and Methods for Their Use
12/13/2012US20120315219 Drug Delivery Coating For Use With A Stent
12/13/2012US20120315218 Toxicology and Cellular Effect of Manufactured Nanomaterials
12/13/2012DE102011118030A1 Herstellung und Verwendung eines Peptids mit einer N-terminalen 11C-markierten Acetylgruppe Preparation and Use of a peptide having an N-terminal 11C-labeled acetyl group
12/13/2012CA2837901A1 Method for the synthesis of porphyrin-phospholipid conjugates
12/12/2012EP2532370A2 Dye solution
12/12/2012EP2532356A1 Implantable power sources and sensors
12/12/2012EP2531221A1 Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis
12/12/2012DE202012104523U1 Mittel für eine mehrdimensionale Modellierung eines in vivo räumlichen Bildes eines MRT-Kontrastmittels Funding for a multi-dimensional modeling of in vivo spatial image of an MRI contrast agent
12/12/2012CN102816203A Substituted quinoline compound, and preparation method, medicine combination and application thereof
12/12/2012CN102816125A Contrast agent
12/12/2012CN102813945A Targeted nanoscale ultrasonic microbubble
12/12/2012CN102813944A Protease-sensitive fluorescent light and magnetism dual-response micro-capsule and preparation method thereof
12/12/2012CN102813943A Contrast agent and preparation method thereof
12/12/2012CN102813678A Biological Chinese patent medicine
12/12/2012CN102813671A Method for building dextran sodium sulphate (DSS) induced enteritis mouse model
12/12/2012CN102430130B Medical modified glucan coated magnetic nanometer particle composite material and preparation method thereof
12/12/2012CN101454026B Novel imaging agents
12/12/2012CN101309976B High-purity texaphyrin metallic complex
12/11/2012US8329212 Abuse potential reduction in abusable substance dosage form
12/11/2012US8329185 Method for isolating and purifying grass pollen allergens
12/11/2012US8329144 Diagnostic and therapeutic epitope, and transgenic plant
12/11/2012US8329143 Method and apparatus for kidney function analysis
12/11/2012CA2513104C Survivin-derived peptides and use thereof
12/11/2012CA2495306C Water soluble metal and semiconductor nanoparticle complexes
12/06/2012WO2012166722A1 Treating colorectal, pancreatic, and lung cancer
12/06/2012WO2012164563A1 Isotopically labeled cdp-choline and uses thereof
12/06/2012WO2012162807A1 Brain tumor targeting peptides and methods
12/06/2012US20120311729 Immunomodulatory Methods and Systems for Treatment and/or Prevention of Atherosclerosis
12/06/2012US20120308657 Magnetic nanostructures as theranostic agents
12/06/2012US20120308654 Abuse-proofed dosage form
12/06/2012US20120308485 Process for the preparaton of novel porphyrin derivatives and their use as pdt agents and fluorescence probes
12/06/2012US20120308484 Clonal strains of attenuated vaccinia viruses and methods of use thereof
12/06/2012US20120308483 Treatment of Sleep Disturbances
12/06/2012US20120308482 Monkey Homolog of Human Interferon Omega
12/06/2012US20120308481 Radio-opaque compounds, compositions containing same and methods of their synthesis and use
12/06/2012US20120308480 Humanized antibodies against tl1a
12/06/2012DE10058538B4 Vorrichtung für MRT-bildgesteuerte Prostata-Biopsie Device for MRI image-guided prostate biopsy
12/06/2012CA2843470A1 Brain tumor targeting peptides and methods
12/06/2012CA2837527A1 Fc receptor binding proteins
12/06/2012CA2837472A1 Rationally-designed anti-mullerian inhibiting substance type ii receptor antibodies
12/05/2012EP2530463A1 Indicator for determining the state of skin
12/05/2012EP2530093A1 Novel indocyanine compound, synthesis method thereof, purification method thereof, diagnostic composition using indocyanine compound, and device for measuring in vivo kinetics and device for visualizing circulation using diagnostic composition
12/05/2012EP2529202A1 Device, system and method for quantifying fluorescence and optical properties
12/05/2012CN202568937U Feeding device for double contrast gas producing agent
12/05/2012CN102811748A Hydroxylated phosphorylated contrast enhancement agents
12/05/2012CN102811747A Solid composition for the oral administration of dyes and diagnostic use thereof
12/05/2012CN102811746A Methods and compositions for nanoparticle-mediated cancer cell-targeted delivery
12/05/2012CN102807517A Synthesis of garlicin derivatives and preparation method for medical ultrasonic couplant with efficient disinfection function using garlicin derivatives
12/05/2012CN102805874A Anal fistula ultrasound contrast liquor
12/05/2012CN102430132B Sterilization type medical ultrasonic coupling agent
12/05/2012CN102294040B Magnetic nanometer polymer vesicle for magnetic resonance imaging and medicine carrier and preparation method of magnetic nanometer polymer vesicle
12/05/2012CN101804211B Establishment of rhesus autoimmune 1 type diabetes model
12/05/2012CN101680934B NMR method for compounds comprising hyperpolarizable core with enhanced sensitivity, in particular phip of application enhancement
12/04/2012US8323962 Molecules with extended half-lives, compositions and uses thereof
12/04/2012US8323889 Process for the production of an abuse-proofed solid dosage form
12/04/2012US8323641 Nanoparticulate compositions having lysozyme as a surface stabilizer
12/04/2012US8323621 site-directed delivery of contrast agent; brain or breast cancer; 1,4,7,10 tetraazacyclododecane having variable chelating ions, phosphoester chains, and light harvesting moieties for changing imaging methods; conjugated to high affinity PBR ligand PK11195; bound to a PVA or a PEG delivery vehicle
12/04/2012US8323619 Contrast agents
12/04/2012US8323618 Ultrasmall superparamagnetic iron oxide nanoparticles and uses thereof
12/04/2012CA2416209C Apparatus and method for polarizing polarizable nuclear species
11/2012
11/29/2012WO2012162318A1 Surgical lighting sources for use with fluophore-tagged monoclonal antibodies or fluorophore-tagged tumor avid compounds
11/29/2012WO2012160990A1 Igf-1r-binding peptide
11/29/2012WO2012160364A1 Contrast agents for biophotonic imaging
11/29/2012US20120304318 Cancer diagnosis and treatment
11/29/2012US20120302909 Methods and systems for screening subjects
11/29/2012US20120302881 Novel indocyanine compound, synthesis method and purification method thereof, diagnostic composition using the indocyanine compound, and device for measuring biokinetics and device for visualizing circulation using the diagnostic composition
11/29/2012US20120302879 Fluorescence-mediated molecular tomography
11/29/2012US20120302654 Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
11/29/2012US20120302557 Biologically active methylene blue derivatives
11/29/2012US20120302514 Glycoconjugates and methods
11/29/2012US20120301404 Treatment of cachexia
11/29/2012US20120301403 Polyethylene glycolated superoxide dismutase mimetics
11/29/2012US20120301402 Rap1a as a marker for cardiac arrhythmia
11/29/2012US20120301401 Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions
11/29/2012US20120301400 Meditopes and meditope-binding antibodies and uses thereof
11/29/2012US20120301397 Diagnosis of macrophage mediated disease
11/29/2012US20120301394 Targeting and in vivo imaging of tumor-associated macrophages
11/28/2012EP2526973A2 X ray contrasting agent for post-mortem, experimental and diagnostic angiography
11/28/2012EP2526971A1 Mucosal delivery of drugs
11/28/2012EP2525835A2 Methods and compositions for nanoparticle-mediated cancer cell-targeted delivery
11/28/2012CN102803967A Protein-based methods and compositions for the diagnosis of colorectal adenocarcinoma
11/28/2012CN102803293A SIGLEC 15 antibodies in treating bone loss-related disease
11/28/2012CN102803270A Gadolinium complex, method for preparing same, and MRI contrast agent comprising same
11/28/2012CN102802672A Imaging of myelin basic protein
11/28/2012CN102802671A Preparation of stabilised X-ray diagnostic composition
11/28/2012CN102796525A Water-phase preparation method of acidity-sensitive CdTe quantum dot modified by double stabilizers
11/28/2012CN102796235A Copolymer based on environmental response and preparation method thereof
11/28/2012CN102796175A Polypeptide bound with high affinity of vasoactive intestinal peptide I type acceptor and application
11/28/2012CN102793932A Application of gold nanorods
11/28/2012CN102793931A CT contrast media for specific targeting tumor neovascularization and preparation method thereof
11/28/2012CN102792919A Method of establishing gnotobiotic animal obesity model and application of model
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 354